Gilead gets WHO cold shoulder for remdesivir in COVID-19, launches speedy defense

·

·

Gilead gets WHO cold shoulder for remdesivir in COVID-19, launches speedy defense

At clear odds with the FDA’s approval, the WHO has recommended against the use of Gilead’s remdesivir in any hospitalized COVID-19 patients—regardless of disease severity. (Getty Images). Share Facebook Twitter LinkedIn Email Print. Gilead Sciences’ …
See Original Article

Apple Suspends New Business For Pegatron On Labor Violations

(Bloomberg) — Apple Inc. suspended new business with key supplier Pegatron Corp. after discovering labor violations at a student workers’ program, taking strong action to clean up its Chinese-focused production chain. The Cupertino, California-based …
See Original Article

KLCI reverses gains to end midday lower

KUALA LUMPUR: The FBM KLCI reversed its earlier gains to end the morning session lower, bucking the trend at regional markets. At 12.30pm the FBM KLCI was 5.8 points lower at 1,513.84. Trading volume hit 6.34 billion shares valued at RM2.61bil.
See Original Article

Brookshire Grocery Co. continues annual food drive to feed local communities

SHREVEPORT, LA – The holidays are quickly approaching, and Brookshire’s grocery company has already began working to help feed those in need. This is the 39th year for their Spirit of Christmas Food Drive. Brookshire’s Grocery. The company’s goal is to …
See Original Article

How to avoid 'junk' fees when getting a mortgage

Closing costs generally equal 2 percent to 5 percent of the amount you’re borrowing for your mortgage. These fees can be broken down into the following: Origination and other lender fees, which can …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.